C. Wolfe

First name
C.
Middle name
D.
Last name
Wolfe
Toschke, A. M., Wolfe, C. D., Heuschmann, P. U., Rudd, A. G., & Gulliford, M. (2009). Antihypertensive treatment after stroke and all-cause mortality\textendashan analysis of the General Practitioner Research Database (GPRD). Cerebrovasc Dis. http://doi.org/10.1159/000223434
Dregan, A., Toschke, M. A., Wolfe, C. D., Rudd, A., Ashworth, M., & Gulliford, M. C. (2011). Utility of electronic patient records in primary care for stroke secondary prevention trials. BMC Public Health. http://doi.org/10.1186/1471-2458-11-86
Gulliford, M. C., Charlton, J., Rudd, A., Wolfe, C. D., & Toschke, A. M. (2010). Declining 1-year case-fatality of stroke and increasing coverage of vascular risk management: population-based cohort study. J Neurol Neurosurg Psychiatry. http://doi.org/10.1136/jnnp.2009.193136
Toschke, A. M., Gulliford, M. C., Wolfe, C. D., Rudd, A. G., & Heuschmann, P. U. (2011). Antihypertensive treatment after first stroke in primary care: results from the General Practitioner Research Database. J Hypertens. http://doi.org/10.1097/HJH.0b013e32833f3897
Dregan, A., van Staa, T. P., McDermott, L., McCann, G., Ashworth, M., Charlton, J., et al. (2014). Point-of-care cluster randomized trial in stroke secondary prevention using electronic health records. Stroke. http://doi.org/10.1161/strokeaha.114.005713
Dregan, A., Charlton, J., Wolfe, C. D., Gulliford, M. C., & Markus, H. S. (2014). Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3651